DSM-Firmenich

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2025-06-23			5-day change	1st Jan Change
94.10 ^CHF	+0.36%		-1.45%	-3.70%

06-16	Swiss stocks - Factors to watch on June 16	RE
06-13	Honeywell & DSM-Firmenich Settle Disputes Related To Honeywell Spectra MG BIO Blue Fiber	RE

DSM-Firmenich AG's Equity Buyback announced on April 8, 2024, has closed with 1,500,000 shares, representing 0.57% for ?156.59 million.

Published on 2024-05-02 at 18:00

The company closed its plan on May 3, 2024.

Latest news about DSM-Firmenich

Swiss stocks - Factors to watch on June 16	06-16	RE
Honeywell & DSM-Firmenich Settle Disputes Related To Honeywell Spectra MG BIO Blue Fiber	06-13	RE
Novonesis Closes Purchase of DSM-Firmenich's Stake in Feed Enzymes Alliance	06-02	MT
Dsm-firmenich Completes EUR 1.5 Bln Sale Of Stake In Feed Enzymes Alliance To Novonesis	06-02	RE
Novonesis A/S (CPSE:NSIS B) completed the acquisition of remaining 50% stake in Feed Enzymes Alliance from DSM-Firmenich AG.	06-01	CI
ABB Lands Automation, Electrical Systems Order from DSM-Firmenich	05-22	MT
Dsm-Firmenich Opens Its Princeton Baking Innovation Center in New Jersey	05-20	CI
DSM-FIRMENICH : Temporary vitamin effect lasts longer	05-02
The stock market has just gained 15% but remains in the fog	04-30
Chemicals maker dsm-firmenich well-placed to mitigate tariff impact	04-30	RE
Chemicals maker dsm-firmenich well-placed to mitigate tariff impact	04-30	RE
DSM-Firmenich AG, Q1 2025 Sales/ Trading Statement Call, Apr 30, 2025	04-30
DSM-Firmenich reports Q1 results slightly below market expectations	04-30	RE
DSM-Firmenich Q1 Sales Rise	04-30	MT
Dsm-firmenich Q1 Sales EUR 3.274 Bln	04-30	RE
DSM-Firmenich Q1 Adj. EBITDA Margin Up At 19.9%	04-30	RE
DSM-Firmenich Appoints New Chief Legal, Risk and Compliance Officer	04-08	MT
DSM-Firmenich AG Announces Executive Changes	04-08	CI
DSM-FIRMENICH : Focus on ESG brings a better future	04-04
Private Equity Firms, Others Explore Bids for DSM-Firmenich's Animal Nutrition Unit	04-03	MT
Private Equity Firms Eye DSM-Firmenich's Animal Nutrition Business, Valued at $3.32 Billion	04-03	MT
Private Equity Firms, Others Explore Bids for DSM-Firmenich's Animal Nutrition Unit	04-03	MT
DSM-Firmenich Completes Shareholding Increase In Andre Pectin To 90.5%	04-03	RE
DSM-Firmenich Increases Stake in Andre Pectin to 91%	04-03	MT
DSM-Firmenich AG acquired an additional 15.50% stake in Yantai Andre Pectin Co. Ltd.	04-02	CI

DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.

Employees

26,301

Sector

Consumer Goods Conglomerates

Calendar

07-31 - Q2 2025 Earnings Release

More about the company